DNA X (SONM)
Non-custodial crypto platform for automated swaps and decentralized-exchange strategies.
Something off on this page? Send us feedback.
Operates a limited-release, non-custodial platform where individual traders configure crypto swaps and automated orders, earning commissions on completed trades. Its sole operating focus followed the sale of the former device business, and transaction activity depends on crypto-market conditions, supported assets, and external service providers.
Provides a limited-release, non-custodial cryptocurrency trading platform for individual users worldwide. The DNA X/DNAX DeFi web platform supports immediate swaps, limit orders, grid/range orders, recurring trades, shareable strategies, and strategy histories; customers retain assets before and after trades. Commissions on completed trades form the revenue model, with the company seeking lower fees and a low-cost operating model.
Operates as the public-company successor to Sonim after the sale of substantially all device and hotspot assets, leaving crypto trading as its sole operating focus. Platform performance remains monitored for bugs, while transaction activity depends on crypto-market conditions and supported assets. Operations rely on a small employee base, contractors, licensed software, and third parties for cloud services, compliance, payments, development, and customer service.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $900.0K · Total debt $2.4M · Total assets $4.5M · Shareholders' equity −$1.2M
- Revenue
- $0
- Operating income
- −$1.3M
- Net income
- −$1.2M
No dividends on record.
| Institutions | 5.94% | 88.4K shares | |
|---|---|---|---|
| 9 holders · as of Jun 30, 2026 | |||
| Insiders | 15.88% | 236.3K shares | |
| 9 holders · as of May 15, 2026 | |||
| Strategic holders | 22.27% | 331.4K shares | |
| 2 holders · as of Feb 20, 2026 | |||
| Other | 55.91% | 832.2K shares | |
| remainder | |||
1.49M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
DNA Holdings Venture Inc.Strategic10 percent owner | 15.00% | 223,201 | filed Feb 20, 2026 |
Laurence W. Lytton1Insider10 percent owner | 8.09% | 120,357 | filed May 15, 2026 |
Orbic North America LLCStrategic10 percent owner | 7.27% | 108,186 | filed Mar 21, 2025 |
Michael C. MulicaInsiderdirector, officer: Acting CEO | 3.63% | 54,071 | filed Feb 10, 2026 |
Clayton CroliusInsiderofficer: Chief Financial Officer | 2.47% | 36,719 | filed Feb 10, 2026 |
- Laurence W. Lytton's transaction reports restate only vehicles that traded; the 2026 ownership statement (120.4K) is used instead.
Insider tradesForm 4
No open-market trades in the last 12 months.
- Coinbase
Scale leader in retail crypto trading and onchain execution.
- Robinhood Markets
Retail crypto venue with an API for automated strategies.
- eToro
Social investing platform with copyable crypto strategies.
- Gemini
Global crypto exchange competing for retail trading activity.
- Coincheck Group
Japanese retail crypto exchange with a trader-focused venue.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DNA X | $4.04 | −0.25% | $6.0M | 1.9 | — | — | −100.0% |
| Coinbase | $198.18 | −1.43% | $53.04B | — | 303.2 | 9.6 | −18.5% |
| Robinhood Markets | $123.99 | +0.56% | $110.86B | 54.3 | 51.0 | 22.5 | +32.3% |
| eToro | $28.16 | −1.78% | $2.41B | 10.6 | 11.4 | 0.3 | +9.1% |
| Gemini | $5.98 | −0.20% | $731.9M | — | — | 3.7 | +32.4% |
| Coincheck Group | $1.87 | +1.08% | $251.5M | — | — | 0.1 | +17.9% |
| Median | 32.4 | 51.0 | 3.7 | +17.9% |